基于桡动脉的多支动脉冠状动脉旁路移植术的有效性:体型的作用
该研究分析6102例接受以左胸廓内动脉为基础的原发冠状动脉旁路移植术患者的15年生存率,按体重指数分组比较桡动脉多支动脉旁路移植与单支动脉旁路移植的生存效果。结果显示桡动脉多支动脉旁路移植在肥胖和非肥胖患者中均带来长期生存优势,且在轻度肥胖者中更明显。
要点
- 桡动脉多支动脉旁路移植在肥胖和非肥胖患者中均与更好的15年生存相关。
- 全肥胖队列中桡动脉多支动脉旁路移植生存获益(HR 0.85,95%CI 0.74-0.98)。
- 轻度肥胖者HR 0.79(95%CI 0.66-0.96),病态肥胖者HR 0.88(95%CI 0.69-1.13)。
核心结论
- 桡动脉多支动脉旁路移植在肥胖和非肥胖患者中均带来长期生存优势。
研究设计与样本
- 分析6102例接受以左胸廓内动脉为基础的原发冠状动脉旁路移植术且移植血管≥2支的患者15年Kaplan-Meier生存。
- 按体重指数分组:非肥胖(<30 kg/m2)和全肥胖(包括轻度肥胖30-35 kg/m2和病态肥胖>35 kg/m2)。
- 通过Cox回归计算桡动脉多支动脉旁路移植对比左胸廓内动脉单支动脉旁路移植的风险校正风险比(HR)及95%置信区间(CI),并分别应用于早期(<0.5年)、中期(0.5-5年)和晚期(5-15年)随访。
- 在各体重指数组内进行桡动脉多支动脉旁路移植与左胸廓内动脉单支动脉旁路移植的倾向性评分匹配作为验证性分析。
主要发现
- 桡动脉多支动脉旁路移植在肥胖患者中更常用(年龄62±10岁;轻度/病态肥胖者中桡动脉多支动脉旁路移植使用率分别为45.4%/54.4%),非肥胖患者使用率为37.4%(年龄66±10岁)。
- 未校正的15年生存率在所有体重指数组中桡动脉多支动脉旁路移植均显著更优。
- 多因素分析显示,全肥胖队列中桡动脉多支动脉旁路移植在整个0-15年研究期间显示生存获益(HR 0.85,95%CI 0.74-0.98),且轻度肥胖者更明显(HR 0.79,95%CI 0.66-0.96),病态肥胖者为HR 0.88(95%CI 0.69-1.13)。
- 桡动脉多支动脉旁路移植的生存获益在术后0.5至5年间实现,全肥胖组(HR 0.69,95%CI 0.51-0.94)与非肥胖组(HR 0.68,95%CI 0.52-0.88)相当。
- 倾向性评分匹配分析为验证性结果。
临床怎么用
- 作者认为桡动脉多支动脉旁路移植在肥胖和非肥胖患者中均带来长期生存优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The multiarterial grafting survival advantage noted in the overall population undergoing coronary artery bypass grafting is not well defined in the obese. We investigated the early to late survival effects of the radial artery in left internal thoracic artery-based multiarterial bypass grafting (radial artery-multiarterial bypass grafting) versus single arterial bypass grafting (left internal thoracic artery-single arterial bypass grafting) in obese patients. METHODS: We analyzed 15-year Kaplan-Meier survival in 6102 patients receiving primary, left internal thoracic artery-based coronary artery bypass grafting with 2 or more grafts divided into body mass index groups: nonobese (<30 kg/m2) and all-obese, comprised of mildly obese (30-35 kg/m2) and morbidly obese (>35 kg/m2). Risk-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of radial artery-multiarterial bypass grafting versus left internal thoracic artery-single arterial bypass grafting were derived via Cox regression and applied separately for early (<0.5 years), intermediate (0.5-5 years), and late (5-15 years) follow-up in each body mass index cohort. Propensity score matching between radial artery-multiarterial bypass grafting and left internal thoracic artery-single arterial bypass grafting cohorts within the body mass index groups was performed as a corroborating analysis. RESULTS: Radial artery-multiarterial bypass grafting was more frequently used in obese patients who were younger (62 ± 10 years; mild/morbid: 45.4%/54.4% radial artery-multiarterial bypass grafting) compared with nonobese patients (66 ± 10 years; 37.4% radial artery-multiarterial bypass grafting). Unadjusted 15-year survival was significantly better for radial artery-multiarterial bypass grafting in all body mass index groups. Multivariate analysis showed a survival benefit of radial artery-multiarterial bypass grafting over the entire 0- to 15-year study period in the all-obese cohort (HR, 0.85; 95% CI, 0.74-0.98) and was more pronounced in the mildly obese (HR, 0.79; 95% CI, 0.66-0.96) versus morbidly obese (HR, 0.88; 95% CI, 0.69-1.13). The radial artery-multiarterial bypass grafting survival benefit was realized between 0.5 and 5 years postoperatively and was comparable for all-obese (HR, 0.69; 95% CI, 0.51-0.94) and nonobese (HR, 0.68; 95% CI, 0.52-0.88) groups. Propensity score matching was confirmatory. CONCLUSIONS: Radial artery-multiarterial bypass grafting confers a long-term survival advantage in both obese and nonobese patients.
引用
- Schwann TA, Ramia PS, Habib JR, et al. Effectiveness of radial artery-based multiarterial coronary artery bypass grafting: Role of body habitus. J Thorac Cardiovasc Surg. 2018. PMID: 29615332. doi:10.1016/j.jtcvs.2018.02.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。